Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation
Background PCSK9is (proprotein convertase subtilisin/kexin type 9 inhibitors) are well tolerated, potently lower cholesterol, and decrease cardiovascular events when added to statins. However, statin adherence may decrease after PCSK9i initiation and alter clinical outcomes. We evaluate the associat...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2023-09-01
|
| Schriftenreihe: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Schlagworte: | |
| Online-Zugang: | https://www.ahajournals.org/doi/10.1161/JAHA.123.029707 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|